Clinic
Altamed Health Services Corp.
Altamed Health Services Corp. was paid $305.80M by Medicaid between Jan 2018 and Dec 2024, across 141 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 98% of everything it billed.
33Billing provider infoALTAMED HEALTH SERVICES CORP.
LOS ANGELES, CA 90027
LOS ANGELES, CA 90027
33aNPI1629283197assigned 05/10/2007
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$305.80M
24GClaims2,506,116
24DCodes billed141
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in California
Rank by total paid#1 of 826
Median peer was paid$4.05M
This provider vs. median76×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official YOUNG, ROBERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 113,616 | $35.94M | |
| 2019 | 343,969 | $39.36M | |
| 2020 | 370,946 | $45.29M | |
| 2021 | 447,880 | $51.66M | |
| 2022 | 370,763 | $36.74M | |
| 2023 | 443,869 | $47.28M | |
| 2024incomplete | 415,073 | $49.53M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 98% | 718,309 | 655,601 | $298.90M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 52,037 | 39,635 | $723K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 47,287 | 38,251 | $688K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 31,656 | 24,001 | $609K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 27,987 | 16,169 | $592K |
| G9920 | Screening performed and negative | <1% | 63,657 | 43,580 | $553K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 8,295 | 7,173 | $412K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 14,382 | 6,784 | $284K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 14,705 | 13,176 | $266K |
| 92551 | <1% | 103,579 | 76,139 | $237K | |
| 90686 | <1% | 102,989 | 75,041 | $218K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 7,630 | 4,196 | $162K |
129 more codes
| 0002A | <1% | 3,263 | $157K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 4,075 | $128K |
| 0072A | <1% | 2,344 | $115K | |
| 0001A | <1% | 6,485 | $115K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,399 | $115K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 449,578 | $111K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 98,371 | $109K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 7,150 | $89K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 181,922 | $72K |
| 83655 | <1% | 11,281 | $71K | |
| 90633 | <1% | 10,316 | $65K | |
| 90651 | <1% | 12,521 | $62K | |
| 90670 | <1% | 13,241 | $58K | |
| 99383 | <1% | 1,674 | $55K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 3,572 | $49K |
| 90680 | <1% | 5,947 | $46K | |
| 90723 | <1% | 5,727 | $40K | |
| 90734 | <1% | 5,812 | $39K | |
| 90716 | <1% | 3,762 | $36K | |
| 90647 | <1% | 6,390 | $35K | |
| 0071A | <1% | 2,860 | $34K | |
| 90710 | <1% | 4,162 | $32K | |
| 90696 | <1% | 3,986 | $32K | |
| 90707 | <1% | 3,524 | $32K | |
| 90715 | <1% | 3,829 | $30K | |
| 90700 | <1% | 3,529 | $29K | |
| 99382 | <1% | 977 | $24K | |
| 99243 | <1% | 2,567 | $23K | |
| 85018 | <1% | 28,413 | $23K | |
| 90697 | <1% | 3,649 | $21K | |
| 99384 | <1% | 579 | $21K | |
| 99381 | <1% | 655 | $20K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 84,943 | $18K |
| 90656 | <1% | 8,553 | $18K | |
| 0004A | <1% | 350 | $17K | |
| 0112A | <1% | 354 | $17K | |
| 90461 | <1% | 82,386 | $17K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,706 | $12K |
| 90671 | <1% | 2,401 | $12K | |
| 90480 | <1% | 4,101 | $12K | |
| 90619 | <1% | 1,870 | $12K | |
| 90648 | <1% | 1,403 | $12K | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 476 | $12K |
| 90677 | <1% | 2,143 | $11K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 5,250 | $9K |
| 0124A | <1% | 944 | $8K | |
| 91321 | <1% | 537 | $7K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,466 | $7K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 324 | $6K |
| 91320 | <1% | 837 | $6K | |
| 92015 | Determination of refractive state | <1% | 23,480 | $5K |
| 90620 | <1% | 526 | $5K | |
| 90744 | <1% | 487 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 740 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 538 | $3K |
| 0154A | <1% | 332 | $3K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,728 | $3K |
| 91319 | <1% | 252 | $2K | |
| 90713 | <1% | 259 | $2K | |
| 90681 | <1% | 302 | $2K | |
| 99245 | <1% | 30 | $2K | |
| 99173 | <1% | 82,156 | $2K | |
| 0074A | <1% | 68 | $2K | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 63 | $2K |
| 92060 | <1% | 9,383 | $2K | |
| 0144A | <1% | 39 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,569 | $1K |
| 90685 | <1% | 147 | $1K | |
| 97802 | <1% | 347 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,519 | $1K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 40 | $995.94 |
| 90732 | <1% | 106 | $936.00 | |
| 91322 | <1% | 75 | $606.84 | |
| 86580 | <1% | 305 | $573.00 | |
| 90381 | <1% | 63 | $567.00 | |
| 90688 | <1% | 265 | $540.72 | |
| G9012 | Other specified case management service not elsewhere classified | <1% | 762 | $276.36 |
| 99000 | <1% | 166 | $265.66 | |
| 99441 | <1% | 26 | $264.16 | |
| 36416 | <1% | 1,543 | $262.90 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,631 | $259.53 |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 3,808 | $173.32 |
| J3490 | Unclassified drugs | <1% | 403 | $165.80 |
| 86756 | <1% | 192 | $145.47 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,134 | $96.81 |
| 93000 | <1% | 168 | $85.23 | |
| 81002 | <1% | 469 | $80.79 | |
| 99242 | <1% | 408 | $50.99 | |
| 3351F | <1% | 6,543 | $46.90 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,497 | $35.13 |
| 3074F | <1% | 14,511 | $25.77 | |
| 3078F | <1% | 14,136 | $25.77 | |
| 88720 | <1% | 74 | $12.54 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 556 | $8.92 |
| 1126F | <1% | 15,899 | $0.30 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 3,175 | $0.00 |
| 0111A | 0% | 41 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 668 | $0.00 |
| 3008F | 0% | 3,746 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 381 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 975 | $0.00 |
| 91307 | 0% | 2,520 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 430 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 654 | $0.00 |
| 0091A | 0% | 20 | $0.00 | |
| 1125F | 0% | 330 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 175 | $0.00 |
| 91315 | 0% | 215 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 115 | $0.00 |
| 90474 | 0% | 106 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 208 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 17 | $0.00 |
| 99355 | 0% | 19 | $0.00 | |
| 99205 | Prolong outpt/office vis | 0% | 20 | $0.00 |
| 90378 | 0% | 30 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 14 | $0.00 |
| 90660 | 0% | 17 | $0.00 | |
| 91309 | 0% | 21 | $0.00 | |
| H0033 | Oral medication administration, direct observation | 0% | 18 | $0.00 |
| 91300 | 0% | 3,990 | $0.00 | |
| 97803 | 0% | 809 | $0.00 | |
| 1160F | 0% | 2,727 | $0.00 | |
| 91311 | 0% | 247 | $0.00 | |
| 1159F | 0% | 528 | $0.00 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 251 | $0.00 |
| 91312 | 0% | 704 | $0.00 | |
| 90473 | 0% | 43 | $0.00 | |
| 17110 | 0% | 18 | $0.00 | |
| 90736 | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYOUNG, ROBERT (VP, PATIENT FINANCIAL SERVICES)
| Provider | Location | Paid |
|---|---|---|
| Altamed Health Services Corp | West Covina, CA | $83.90M |
| Altamed Health Services Corp | Pico Rivera, CA | $70.97M |
| Altamed Health Services Corp | El Monte, CA | $56.32M |
| Altamed Health Services Corp | Huntington Beach, CA | $53.30M |
| Altamed Health Services Corp | Los Angeles, CA | $50.84M |
| Altamed Health Services Corp | Santa Ana, CA | $43.62M |
| Altamed Health Services Corp | Santa Ana, CA | $40.31M |
| Altamed Health Services Corp | E. Los Angeles, CA | $33.24M |
| Altamed Health Services Corp | Garden Grove, CA | $30.84M |
| Altamed Health Services Corp | Los Angeles, CA | $23.94M |
| Altamed Health Services Corp | Orange, CA | $19.54M |
| Altamed Health Services Corp | Pico Rivera, CA | $14.32M |
| Altamed Health Services Corp | Anaheim, CA | $7.95M |
| Robert L. Young, JR. , DDS | Charlotte, NC | $7.89M |
| Altamed Health Services Corp | Los Angeles, CA | $3.75M |
| Altamed Health Services Corp | Anaheim, CA | $3.62M |
| Altamed Health Services Corp | Anaheim, CA | $3.60M |
| Robert L Young 2 DDS PA | Mint Hill, NC | $2.39M |
| Altamed Health Services Corp | Los Angeles, CA | $2.03M |
| Altamed Health Services Corporation | Los Angeles, CA | $1.50M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.